BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 22, 2011
View Archived Issues
Merck KGaA presents novel PDK1 inhibitors with potential to treat cancer
Read More
Innovative oral MS therapy advances to phase IIa
Read More
Summit identifies new approach to treat Alzheimer's disease
Read More
Clinical studies evaluate lersivirine versus efavirenz in HIV and its effect on methadone PK
Read More
New androgen receptor antagonists reported
Read More
S*BIO discloses novel mTOR inhibitors
Read More
Novel histamine H4 receptor antagonists prepared by Palau Pharma
Read More
Pfizer divulges new MPGES-1 inhibitors for pain
Read More
Japanese company patents new angiotensin AT receptor antagonists/PPAR-gamma agonists
Read More
D-Pharm clear to continue phase III DP-b99 study
Read More
Phase II Aimspro trial for bladder dysfunction in MS advances
Read More
Aeterna Zentaris reports nonclinical milestone for oral prostate cancer vaccine
Read More
Millennium files sNDA to add survival data to Velcade MM label in U.S.
Read More
Pfizer's new opioid NOP receptor antagonists show preclinical potential to treat AD
Read More
Potent serotonin 5-HT4 receptor agonist described by Suven
Read More
NanoCarrier and Orient Europharma commence phase II study of Nanoplatin
Read More
Cellceutix cleared to conduct phase I trial of anticancer drug
Read More
Regulus Therapeutics and GSK alliance identifies third microRNA target
Read More
EMA accepts Santhera Pharmaceuticals' idebenone MAA for review
Read More
First-in-human trial assesses effects of GSK-1034702 on cognitive function
Read More
Merck & Co. and Simcere sign agreement to establish joint venture in China
Read More
FDA issues safety warning regarding use of Multaq in patients with permanent AF
Read More
Bristol-Myers Squibb to acquire Amira Pharmaceuticals
Read More
Manhattan Pharmaceuticals and FDA reach agreement on SPA for phase III AST-726 trial
Read More
Apricus files MAA in Switzerland for Vitaros
Read More